Cilian AG is an innovative biotechnology enterprise, which uses the unique abilities of Ciliates, a new class of production organisms, for the industrial production of therapeutic proteins. The company is working on production of vaccines, monoclonal antibodies as well as on oral enzyme preparation for the substitution therapy of pancreatic insufficiency. By using a new class of production organism (Ciliates) Cilian AG can design the production process substantially safer, more efficient and more cost-effective as this is currently possible for comparable proteins with mammalian cells. Moreover it is expected, that monoclonal antibodies can be developed and produced significantly more effective.
Cilian is offering this unique technology as CIBEX-System to Pharma- and Biotech companies.
Company Details
- Employees
- 5
- Phone
- +49 251 620 31-0
- in****@****lian.de
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cilian.com
- Keywords
- Biotech Research & Development.
Cilian Ag Questions
Cilian Ag's helpline number is +49 251 620 31-0
Cilian Ag's website is cilian.com
Cilian Ag's LinkedIn profile is https://de.linkedin.com/company/cilian-ag
Cilian Ag has
5 employees.
View email and phone details for 5
employees at Cilian Ag.
Cilian Ag's industry is
Biotechnology Research
Cilian Ag's top competitors are
Evorion Biotechnologies Gmbh,
Pl Bioscience Gmbh,
Cytiva,
Evoxx Technologies Gmbh,
Qima Life Sciences,
Numaferm,
Bioecho Life Sciences,
4biocell Gmbh & Co. Kg,
Rottendorf Pharma,
Cube Biotech.
Cilian Ag's support email address is info@cilian.de
Cilian Ag's categories are Biotechnology Research
